Advertisement
News
Subscribe to MDT Magazine News

HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting

April 12, 2011 3:33 am | by Bio-Medicine.Org | Comments

FRAMINGHAM, Mass. and SYDNEY, April 12, 2011 /- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the...

TOPICS:

Reportlinker Adds North America Neurology Devices Market Outlook to 2017

April 12, 2011 3:32 am | by Bio-Medicine.Org | Comments

NEW YORK, April 12, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: North America Neurology Devices Market Outlook to 2017 http://www.reportlinker.com/p0336547/North-America-Neurology-Devices-Market-Outlook-to-2017.html North America...

TOPICS:

Smokers believe 'silver', 'gold' and 'slim' cigarettes are less harmful

April 11, 2011 8:38 pm | by EurekAlert | Comments

(Wiley-Blackwell) Despite current prohibitions on the words 'light' and 'mild', smokers in Western countries continue falsely to believe that some cigarette brands may be less harmful than others.

TOPICS:
Advertisement

Skilled Healthcare Group board eyes potential sale

April 11, 2011 5:45 pm | by The Associated Press | Comments

Skilled Healthcare Group Inc. said Monday its board of directors is exploring strategic alternatives, including the potential sale of the company or some of its real estate assets.The nursing home operator said it has engaged J.P. Morgan Securities LLC to assist in the process.The board has not...

Cardinal Health director Mongan resigns

April 11, 2011 1:45 pm | by The Associated Press | Comments

Health care services company Cardinal Health Inc. said Monday that Dr. James J. Mongan is resigning from the company's board of directors because of health-related considerations, according to a filing with the Securities and Exchange Commission.Mongan was named to the board of directors in...

Tenet, Community Health fight gets nasty

April 11, 2011 12:45 pm | by TOM MURPHY - AP Business Writer - Associated Press | Comments

Tenet Healthcare has charged rival hospital operator Community Health Systems with systematically bilking Medicare, and the burgeoning legal fight sent shares of the entire sector sliding Monday.The charges come months after Community launched a $3 billion hostile takeover bid for Tenet. The...

Scientists find method to probe genes of the most common bacterial STI

April 11, 2011 12:38 pm | by EurekAlert | Comments

(NIH/National Institute of Allergy and Infectious Diseases) In a new study from the NIAID, scientists describe successfully mutating specific genes of Chlamydia bacteria, which cause the most common sexually transmitted infection in the United States as well as a type of blindness...

TOPICS:

CarePoint Partners Expands Texas Presence and Opens Georgia Market With Acquisition of Premier Infusion

April 11, 2011 12:36 pm | by Bio-Medicine.Org | Comments

CINCINNATI, April 11, 2011 /- CarePoint Partners (CarePoint) today announced that it has acquired Premier Infusion (Premier). Premier provides home infusion pharmacy services in Austin, Texas and infusion pharmacy and related nursing services in the Atlanta, Georgia area. The Austin...

TOPICS:
Advertisement

ImaginAb, Inc. and Dainippon Seiki (DNS) Co., Ltd. Conclude Technology Development Agreement for Automated Chemistry Systems

April 11, 2011 12:33 pm | by Bio-Medicine.Org | Comments

LOS ANGELES and KYOTO, Japan, April 11, 2011 /- ImaginAb, Inc. and Dainippon Seiki Co., Ltd. have concluded a technology agreement around the development of automated chemistry systems for fluorination of proteins and peptides for diagnostic imaging with positron emission tomography...

TOPICS:

Summary Box: Tenet sues Community Health

April 11, 2011 11:45 am | by The Associated Press | Comments

GLOVES COME OFF: Tenet Healthcare Corp. filed a federal lawsuit against Community Health Systems Inc., which has launched a hostile bid for the fellow hospital operator.LEFT HOOK: Tenet says Community systematically bilks Medicare by admitting thousands of patients that should only be kept for...

Proto Labs Launches Cool Idea! Award to Support Tomorrow's Innovators

April 11, 2011 10:50 am | Comments

MAPLE PLAIN, Minn. – April 11, 2011 –Proto Labs, the world's fastest manufacturer of CNC machined and injection-molded parts, has announced the launch of its Cool Idea! award, a new program designed to give product designers the opportunity to bring innovative products to life. Proto Labs will provide $100,000 worth of prototyping and short-run production services to award recipients.

Glaucoma patients report a wide range of emotional and psychological changes

April 11, 2011 10:39 am | by EurekAlert | Comments

(Wiley-Blackwell) Fear of the unknown is one of the greatest issues facing patients with glaucoma, the second leading cause of blindness worldwide after cataracts. Researchers spoke to 24 people with glaucoma, which can lead to severe restriction of the visual field and...

TOPICS:

Biotech vet Kennedy takes Mascoma executive R & D post

April 11, 2011 10:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Mascoma Corp. has named former Genzyme Corp. senior VP Stephen Kennedy as executive vice president of research and development of the cellulosic ethanol firm in Lebanon, N.H. In his new role, Kennedy will lead the company's efforts to move its research into commercialization.

Boston Biomedical in $15 million-plus deal with Dainippon(2)

April 11, 2011 10:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Norwood-based Boston Biomedical Inc. (BBI) has signed a license agreement with Dainippon Sumitomo Pharma Co. Ltd. of Osaka, Japan, for BBI's BBI608 candidate compound for all oncology indications.

Boston Biomedical in $15 million-plus deal with Dainippon

April 11, 2011 10:37 am | Comments

Norwood-based Boston Biomedical Inc. (BBI) has signed a license agreement with Dainippon Sumitomo Pharma Co. Ltd. of Osaka, Japan, for BBI's BBI608 candidate compound for all oncology indications.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading